Big Pharma Split Corp. (PRM.TO) TSX

Currency In CAD

AD

Valuation

Market Cap17.04M
Enterprise Value28.85M
P/E Ratio3.84
PEG Ratio-0.01
Price/Sales Ratio-17.43
Price/Book Ratio0.92
Enterprise/Revenue-28.87
Enterprise/EBITDA5.93

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-4.26
Operating Margin-3.89
AD

Management Effectiveness

Return On Assets0.14
Return On Equity0.28

Income Statement

Revenue1.45M
Revenue/Share-0.85
Gross Profit1.14M
EBITDA5.03M
Net Income4.4M
Diluted EPS3.59

Balance Sheet

Total Cash31.22M
Total Cash/Share25.59
Total Debt13.17M
Total Debt/Equity0.72
Current Ratio2.33
Book Value Per Share14.97

Price History

52-Week Change22.76
52-Week High15.5
52-Week Low10.71
Moving Average 50 Days13.67
Moving Average 200 Days13.53

Statistics

Average Volume2,100
Shares Outstanding1.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.24
Trailing Annual Dividend Yield8.96
Payout Ratio0.41
Last Split FactorN/A
Last Split DateN/A
AD